ArticlePoultry science2026
Dietary marigold-derived lutein produces dose- and time-dependent egg yolk enrichment and coordinated hepatic-ovarian responses in laying hens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marigold-derived lutein is widely used to enhance egg yolk pigmentation, but its dose-dependent deposition efficiency, temporal accumulation, post-withdrawal clearance, and associated hepatic-ovarian responses remain incompletely defined. This study evaluated these responses in 450 23-wk-old Jingfen No. 6 laying hens assigned to diets containing 0, 40, 80, 120, or 160 mg/kg marigold-derived lutein for 12 wk, with 6 replicates of 15 hens per treatment. Dietary lutein did not affect overall laying performance or conventional egg-quality traits (P > 0.05). Yolk color increased rapidly in a dose-responsive manner from D3 of supplementation and remained elevated through D28 (P < 0.001). At D21, egg lutein content increased with supplementation level (P < 0.001), whereas incremental apparent deposition efficiency declined from 8.42% at 40 mg/kg to 5.28% at 160 mg/kg (P = 0.016). After withdrawal, egg lutein content remained relatively stable during the first 3 d, declined sharply between WD3 and WD7, and no longer differed among groups by WD10. Exploratory analyses comparing the 0 and 120 mg/kg groups showed that hens fed 120 mg/kg lutein had lower serum total cholesterol, LDL-C, VLDL, and MTTP and higher vitellogenin, estradiol, luteinizing hormone, and follicle-stimulating hormone (P < 0.05). It also decreased hepatic BCO2, PPARγ, and apoVLDL-II expression, while increasing hepatic ERα and ApoA1 and ovarian VLDLR, ApoA1, and ERα expression (P < 0.05). Serum estradiol was positively correlated with ovarian ERα and ApoA1, and serum vitellogenin was positively correlated with ovarian VLDLR. These findings show that marigold-derived lutein rapidly enriches egg yolk, but incremental apparent deposition efficiency declines at higher dietary inclusion levels. Continuous supplementation was required to maintain enrichment, and the serum and transcriptional responses observed at 120 mg/kg were consistent with reduced hepatic carotenoid cleavage, altered circulating endocrine and lipid-related status, and greater ovarian yolk-precursor uptake capacity, which may jointly favor lutein deposition in egg yolk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.